Clasp Therapeutics
Clasp Therapeutics is a biotechnology company developing modular T cell engagers (TCEs) for precise immuno-oncology treatments. Their platform targets oncogenic driver mutations, creating off-the-shelf medicines to address hard-to-treat cancers with high specificity. This approach aims to eradicate tumors while minimizing toxicity.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $150M
Date: 20-Mar-2024
Investors: Catalio Capital Management, Third Rock Ventures, Novo Holdings, Vivo Capital, Cure Ventures, Blackbird BioVentures, Pictet Alternative Advisors, American Cancer Society’s Bright Edge, Alexandria Venture Investments
Markets: Biotechnology, Therapeutics
HQ: Rockville, Maryland, United States
Founded: 2020
Website: https://www.clasptx.com/home#about-us
LinkedIn: https://www.linkedin.com/company/clasp-therapeutics
Crunchbase: https://www.crunchbase.com/organization/clasp-therapeutics
Leave a Comment
Comments
No comments yet.